PT2150282T - Composições e métodos para formação do suporte - Google Patents
Composições e métodos para formação do suporteInfo
- Publication number
- PT2150282T PT2150282T PT87382230T PT08738223T PT2150282T PT 2150282 T PT2150282 T PT 2150282T PT 87382230 T PT87382230 T PT 87382230T PT 08738223 T PT08738223 T PT 08738223T PT 2150282 T PT2150282 T PT 2150282T
- Authority
- PT
- Portugal
- Prior art keywords
- compositions
- methods
- scaffold formation
- scaffold
- formation
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterized by the type of post-polymerisation functionalisation
- C08G2650/04—End-capping
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterized by the type of post-polymerisation functionalisation
- C08G2650/20—Cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Pathology (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90776507P | 2007-04-16 | 2007-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2150282T true PT2150282T (pt) | 2018-07-09 |
Family
ID=39864459
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT87382230T PT2150282T (pt) | 2007-04-16 | 2008-04-16 | Composições e métodos para formação do suporte |
PT121675102T PT2497505T (pt) | 2007-04-16 | 2008-04-16 | Composições e métodos para a formação de armações |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT121675102T PT2497505T (pt) | 2007-04-16 | 2008-04-16 | Composições e métodos para a formação de armações |
Country Status (8)
Country | Link |
---|---|
US (2) | US9624259B2 (pt) |
EP (2) | EP2150282B1 (pt) |
DK (2) | DK2497505T3 (pt) |
ES (2) | ES2672510T3 (pt) |
PL (2) | PL2497505T3 (pt) |
PT (2) | PT2150282T (pt) |
TR (1) | TR201809112T4 (pt) |
WO (1) | WO2008126092A2 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7288608B2 (en) | 2001-10-10 | 2007-10-30 | Regents Of The University Of Colorado | Degradable thiol-ene polymers |
US7842667B2 (en) | 2003-12-22 | 2010-11-30 | Regentis Biomaterials Ltd. | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
DK1722834T3 (da) * | 2003-12-22 | 2012-10-22 | Regentis Biomaterials Ltd | Matrix, som omfatter naturligt forekommende tværbundet proteinskelet |
TR201809112T4 (tr) | 2007-04-16 | 2018-07-23 | Regentis Biomaterials Ltd | İskele oluşturmak i̇çi̇n bi̇leşi̇mler ve yöntemler. |
WO2009120995A2 (en) | 2008-03-27 | 2009-10-01 | Purdue Research Foundation | Collagen-binding synthetic peptidoglycans, preparation, and methods of use |
WO2010064251A1 (en) | 2008-12-04 | 2010-06-10 | Technion Research & Development Foundation Ltd | Hydrogel sponges, methods of producing them and uses thereof |
IL195764A0 (en) | 2008-12-07 | 2009-11-18 | Technion Res & Dev Foundation | Compositions and methods for drug delivery |
CN106039401A (zh) * | 2009-12-16 | 2016-10-26 | 瑞吉恩提斯生物材料有限公司 | 由聚合物‑蛋白质结合物形成的支架,产生该支架的方法及其用途 |
JP5876045B2 (ja) | 2010-07-12 | 2016-03-02 | ユニバーシティー オブ サザン カリフォルニア | 幹細胞と標的組織の相互接続を促進する生体適合性基材およびそれを埋め込む方法 |
US20140038826A1 (en) | 2011-01-28 | 2014-02-06 | The Regents Of The University Of Colorado, A Body Corporate | Covalently cross linked hydrogels and methods of making and using same |
US10478206B2 (en) | 2011-04-29 | 2019-11-19 | University Of Southern California | Instruments and methods for the implantation of cell-seeded substrates |
US8877489B2 (en) | 2011-12-05 | 2014-11-04 | California Institute Of Technology | Ultrathin parylene-C semipermeable membranes for biomedical applications |
ES2708076T3 (es) | 2011-05-24 | 2019-04-08 | Symic Ip Llc | Peptidoglicanos sintéticos que se unen al ácido hialurónico, preparación y métodos de uso |
US9248013B2 (en) | 2011-12-05 | 2016-02-02 | California Institute Of Technology | 3-Dimensional parylene scaffold cage |
US9988433B2 (en) | 2013-03-14 | 2018-06-05 | Mosaic Biosciences, Inc. | Covalent modification of biological macromolecules |
EP2822533B1 (en) | 2012-02-02 | 2021-01-20 | Mosaic Biosciences, Inc. | Biomaterials for delivery of blood extracts and methods of using same |
JP6603650B2 (ja) | 2013-03-15 | 2019-11-06 | パーデュー・リサーチ・ファウンデーション | 細胞外マトリックス結合性合成ペプチドグリカン |
US10772931B2 (en) | 2014-04-25 | 2020-09-15 | Purdue Research Foundation | Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction |
BR112017017029A2 (pt) | 2015-02-09 | 2018-04-10 | Mosaic Biosciences Inc | polímeros de tiol-eno degradáveis e métodos para a sua fabricação |
US20160303281A1 (en) * | 2015-04-17 | 2016-10-20 | Rochal Industries, Llc | Composition and kits for pseudoplastic microgel matrices |
WO2017103914A1 (en) * | 2015-12-17 | 2017-06-22 | Regentis Biomaterials Ltd. | Ready for use organic solvent free compositions comprising protein-polymer conjugates and uses thereof |
EP3436076A1 (en) | 2016-03-30 | 2019-02-06 | Regentis Biomaterials Ltd. | Treatments utilizing a polymer-protein conjugate |
KR20200026263A (ko) | 2017-07-07 | 2020-03-10 | 시믹 아이피, 엘엘씨 | 합성 생체접합체 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE431758B (sv) * | 1977-03-04 | 1984-02-27 | Pharmacia Fine Chemicals Ab | Som tioleringsreagens eller berarmatris for enzymer anvendbart derivat av en sh-grupphaltig polymer |
US6284503B1 (en) * | 1993-08-20 | 2001-09-04 | University Of Utah Research Foundation | Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
WO1995015352A1 (en) | 1993-12-01 | 1995-06-08 | Universite Du Quebec A Montreal | Albumin based hydrogel |
AU3862900A (en) * | 1999-03-01 | 2000-09-21 | Uab Research Foundation | Porous tissue scaffolding materials and uses thereof |
US6680063B1 (en) * | 1999-10-08 | 2004-01-20 | Providence Health System-Oregon | Biocompatible albumin lamina and method |
US6620927B2 (en) * | 2001-02-22 | 2003-09-16 | Anika Therapeutics, Inc. | Thiol-modified hyaluronan |
US7345150B2 (en) * | 2002-03-26 | 2008-03-18 | Medical University Of Toledo | Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use |
ZA200604869B (en) | 2003-12-04 | 2007-11-28 | Univ Utah Res Found | Modified macromolecules and methods of making and using thereof |
DK1722834T3 (da) | 2003-12-22 | 2012-10-22 | Regentis Biomaterials Ltd | Matrix, som omfatter naturligt forekommende tværbundet proteinskelet |
TR201809112T4 (tr) | 2007-04-16 | 2018-07-23 | Regentis Biomaterials Ltd | İskele oluşturmak i̇çi̇n bi̇leşi̇mler ve yöntemler. |
-
2008
- 2008-04-16 TR TR2018/09112T patent/TR201809112T4/tr unknown
- 2008-04-16 EP EP08738223.0A patent/EP2150282B1/en not_active Not-in-force
- 2008-04-16 WO PCT/IL2008/000521 patent/WO2008126092A2/en active Application Filing
- 2008-04-16 EP EP12167510.2A patent/EP2497505B1/en not_active Not-in-force
- 2008-04-16 US US12/595,970 patent/US9624259B2/en active Active
- 2008-04-16 ES ES08738223.0T patent/ES2672510T3/es active Active
- 2008-04-16 PT PT87382230T patent/PT2150282T/pt unknown
- 2008-04-16 PT PT121675102T patent/PT2497505T/pt unknown
- 2008-04-16 PL PL12167510T patent/PL2497505T3/pl unknown
- 2008-04-16 PL PL08738223T patent/PL2150282T3/pl unknown
- 2008-04-16 ES ES12167510.2T patent/ES2596707T3/es active Active
- 2008-04-16 DK DK12167510.2T patent/DK2497505T3/en active
- 2008-04-16 DK DK08738223.0T patent/DK2150282T3/en active
-
2017
- 2017-03-15 US US15/459,007 patent/US20170182214A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT2497505T (pt) | 2016-11-14 |
US9624259B2 (en) | 2017-04-18 |
ES2672510T3 (es) | 2018-06-14 |
TR201809112T4 (tr) | 2018-07-23 |
WO2008126092A3 (en) | 2009-10-22 |
DK2150282T3 (en) | 2018-07-23 |
PL2150282T3 (pl) | 2018-10-31 |
EP2497505B1 (en) | 2016-08-10 |
EP2150282A2 (en) | 2010-02-10 |
EP2150282B1 (en) | 2018-04-11 |
PL2497505T3 (pl) | 2017-02-28 |
DK2497505T3 (en) | 2016-12-05 |
ES2596707T3 (es) | 2017-01-11 |
US20100137510A1 (en) | 2010-06-03 |
EP2497505A1 (en) | 2012-09-12 |
US20170182214A1 (en) | 2017-06-29 |
WO2008126092A2 (en) | 2008-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2497505T (pt) | Composições e métodos para a formação de armações | |
ZA201001300B (en) | Antigen-asjuvant compositions and methods | |
PL2137210T3 (pl) | Nowy sposób i kompozycje | |
IL210153A0 (en) | Nutrigenomics methods and compositions | |
EP2035014A4 (en) | FUCOIDANE PREPARATIONS AND METHODS | |
IL195619A0 (en) | Compositions and methods for joininig non-conjoined iumens | |
IL212822A0 (en) | Anti-cxcr1 compositions and methods | |
GB0815872D0 (en) | Novel method and compositions | |
GB0819530D0 (en) | Methods and compositions | |
IL210559A0 (en) | Novel compositions and methods | |
EP2152247A4 (en) | COMPOSITIONS AND METHODS ANTI-INSOMNIA | |
GB0721291D0 (en) | Methods and compositions | |
EP2370815A4 (en) | ANTI-INFLAMMATORY COMPOSITIONS AND RELATED METHODS | |
HUE037121T2 (hu) | Új készítmények és eljárások | |
IL205248A0 (en) | Compositions and methods for making androstenediones | |
GB0817585D0 (en) | Novel compositions and methods | |
GB0719526D0 (en) | Compositions and methods | |
HRP20150021T1 (en) | Phenanthrenone compounds, compositions and methods | |
GB0811250D0 (en) | Methods and compositions | |
GB0717683D0 (en) | Compositions and methods | |
GB0723775D0 (en) | Methods and compositions | |
GB0724549D0 (en) | Compositions and methods | |
GB0707188D0 (en) | Novel method and compositions | |
GB0816534D0 (en) | Compositions and methods | |
GB0803464D0 (en) | Methods and compositions |